Alector (ALEC) Change in Cash (2018 - 2026)
Alector's (ALEC) quarterly Change in Cash came in at -$17.0 million in Q2 2026, down 350.76% year-over-year from $6.8 million in Q2 2025, and down 252.75% quarter-over-quarter from $11.2 million in Q1 2026.
Analysis
Alector (ALEC) Change in Cash (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Cash for 9 consecutive years, with -$17.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Cash fell 350.76% year-over-year to -$17.0 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 712.13% increase from a year earlier, with the FY2025 full-year figure at $32.8 million, up 179.5% from the prior year.
- Change in Cash was -$17.0 million for Q2 2026 at Alector, down from $11.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $125.5 million in Q1 2022 and troughed at -$282.4 million in Q2 2022.
- A 5-year average of -$14.9 million and a median of -$7.1 million in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash slumped 1981.11% in 2022 and jumped 405.53% in 2025, its largest moves.
- Over 5 years, Change in Cash stood at -$29.9 million in 2022, then advanced by 8.36% to -$27.4 million in 2023, then surged by 86.0% to -$3.8 million in 2024, then slumped by 178.82% to -$10.7 million in 2025, then plunged by 59.3% to -$17.0 million in 2026.
- The last three Change in Cash figures came in at -$17.0 million (Q2 2026), $11.2 million (Q1 2026), and -$10.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -17.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.05 Mn |
| Mar 31, 2026 | 11.16 Mn |
| Dec 31, 2025 | -10.70 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Jun 30, 2024 | -25.01 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Dec 31, 2023 | -27.41 Mn |
| Sep 30, 2023 | -29.58 Mn |
| Jun 30, 2023 | -63.94 Mn |
| Mar 31, 2023 | 41.23 Mn |
| Dec 31, 2022 | -29.91 Mn |
| Sep 30, 2022 | 11.97 Mn |
| Jun 30, 2022 | -282.36 Mn |
| Mar 31, 2022 | 125.47 Mn |
| Dec 31, 2021 | -187.38 Mn |
| Sep 30, 2021 | 390.82 Mn |